Recombinant Xenopus laevis Myelin protein zero-like protein 3 (mpzl3) is a recombinant form of a protein derived from the African clawed frog, Xenopus laevis. This protein is part of the myelin protein zero-like family, which plays roles in cell adhesion and potentially in neurological functions. Despite its name, myelin protein zero-like proteins are not directly involved in myelination but share structural similarities with myelin protein zero, a key component of compact myelin in the nervous system.
| Property | Description |
|---|---|
| CAS Number | Not specified |
| Molecular Formula | Not specified |
| Molecular Weight | Not specified |
| Synonyms | Recombinant Xenopus laevis Myelin protein zero-like protein 3 |
Recombinant Xenopus laevis Myelin protein zero-like protein 3 (mpzl3) is available from suppliers such as CUSABIO TECHNOLOGY LLC, based in China. The preparation involves recombinant DNA technology, where the gene encoding mpzl3 is inserted into an expression vector and expressed in a suitable host organism, typically bacteria or mammalian cells.
| Supplier | Country | Contact |
|---|---|---|
| CUSABIO TECHNOLOGY LLC | China | 027-87196173, cusabio@163.com |
While specific research on Recombinant Xenopus laevis Myelin protein zero-like protein 3 (mpzl3) is limited, studies on related proteins suggest they may play roles in cell adhesion and potentially in immune responses or neurological diseases. For example, myelin protein zero-like 3 (MPZL3) in humans has been studied for its potential role in cancer prognosis and immune cell infiltration .
MPZL3 in humans is expressed in various tissues and has been implicated in cancer prognosis, with high expression associated with altered drug sensitivity and immune cell infiltration . While the specific function of mpzl3 in Xenopus laevis is less clear, it likely shares similar roles in cell adhesion and potentially in developmental or immune processes.
In other contexts, such as systemic lupus erythematosus (SLE) and moyamoya disease, MPZL3 has been identified as a potential biomarker due to its differential expression . This suggests that myelin protein zero-like proteins could have broader implications in disease diagnosis and prognosis across different species.
Mediates homophilic cell-cell adhesion.
KEGG: xla:379105
UniGene: Xl.13209
Myelin protein zero-like protein 3 (mpzl3) is a transmembrane protein related to the myelin protein zero (P0) family, which plays critical roles in myelin formation. Xenopus laevis serves as an excellent model for studying mpzl3 due to its unique advantages in developmental biology research, including large, abundant eggs and readily manipulated embryos that share conserved cellular, developmental, and genomic organization with mammals . The long fertility period of Xenopus (ten years or more) simplifies maintenance of genetic stocks for experimental studies compared to other animal models . Additionally, Xenopus embryos provide substantial material for biochemical work, yielding approximately five times more material per embryo than smaller model organisms, making them ideal for proteomics and structural biology studies of proteins like mpzl3 .
Myelin protein zero (P0), a related protein to mpzl3, is essential for the formation and maintenance of peripheral nervous system (PNS) compact myelin . While mpzl3 shares structural similarities with P0, it likely has distinct functions in myelin organization. In Xenopus, myelin proteins demonstrate unique properties - for instance, Xenopus P0 forms dimers that appear to be stabilized by non-covalent interactions, with an equilibrium between dimer and monomer forms in native myelin . This dimerization behavior might also be relevant for understanding mpzl3 function, as related proteins often share structural and functional characteristics. Research suggests that post-translational modifications, particularly glycosylation and acylation, play important roles in protein interaction and oligomerization of myelin proteins in Xenopus .
For studying mpzl3 expression across Xenopus developmental stages, quantitative proteomics offers a powerful approach. Following the protocol established for developmental time series analysis, researchers can:
Collect embryos at critical developmental stages (from egg to stage 35)
Prepare protein samples using established extraction protocols
Apply multiplexed proteomics techniques to acquire mass spectra
Convert approximately 700,000 acquired mass spectra into protein expression dynamics
This methodology has successfully tracked expression dynamics for approximately 9,000 proteins across Xenopus development and can be readily adapted for focusing on mpzl3 specifically . Quality control analysis should be performed before full-scale analysis to identify any errors that occurred during sample preparation, ensuring reliable results .
Based on successful approaches used for related myelin proteins in Xenopus, the following integrated workflow is recommended:
In-gel glycosidase and protease digestions
Permethylation of released glycans
Mass spectrometry analysis (particularly ESI-FT MS/MS with CAD)
This approach has proven effective in elucidating detailed glycosylation profiles of myelin proteins in Xenopus. For instance, this methodology successfully characterized Asn92 (corresponding to Asn93 in higher vertebrates) as a fully-occupied N-glycosylation site in myelin protein zero . Similar sites may exist in mpzl3 and could be identified using this methodology. Researchers should pay particular attention to glycosylation and acylation, as these modifications typically influence protein interaction and oligomerization behaviors .
The following workflow is recommended based on established proteomics protocols for Xenopus:
| Analysis Stage | Recommended Method | Purpose |
|---|---|---|
| Preliminary Analysis | Quality-control assessment | Identify sample preparation errors |
| Peptide/Protein Identification | MaxQuant proteomics pipeline | Control error rates in identification |
| Quantification | MaxQuant with appropriate parameters | Quantify peptide and protein species |
| Data Interpretation | Clustering analysis | Identify co-regulated proteins |
| Functional Analysis | Gene-set enrichment analysis | Determine biological pathways involved |
The freely available MaxQuant proteomics pipeline has been successfully employed for Xenopus proteomics studies and is recommended for mpzl3 research . This workflow ensures robust identification and quantification of proteins while enabling biological interpretation of the data through downstream analyses.
Distinguishing mpzl3 from related proteins like myelin protein zero requires careful attention to peptide mass fingerprinting. When analyzing proteomic data:
Achieve at least 60% amino acid sequence coverage (as demonstrated for related proteins)
Pay special attention to unique peptide sequences that differentiate mpzl3 from other myelin proteins
Compare peptide mass fingerprints obtained from in-gel proteolysis
Use continuous elution gel electrophoresis for large-scale purification when necessary
It's important to note that related proteins may share significant sequence homology, making careful analysis essential. For example, in studies of Xenopus myelin protein zero, researchers achieved more than 60% amino acid sequence coverage, allowing definitive identification . Similar coverage should be targeted for mpzl3 studies.
Xenopus provides excellent opportunities for both gain-of-function and loss-of-function studies of mpzl3:
Gain-of-function studies: Exploit injection of mRNA into Xenopus laevis embryos to assess mpzl3 overexpression effects on development and myelin formation .
Loss-of-function studies: While traditionally challenging in X. laevis, several approaches are now available:
Genetic mapping: Simple sequence length polymorphisms (SSLP) mapping can facilitate positional cloning of mutations related to mpzl3 function .
The combination of genetic approaches in both X. laevis and X. tropicalis provides a powerful system for comprehensive functional studies of mpzl3.
Based on studies of related myelin proteins in Xenopus that exhibit dimerization behavior, the following approaches are recommended:
Gel electrophoresis analysis: Compare dimer and monomer forms through in-gel proteolysis followed by peptide mass fingerprinting
Large-scale purification: Use continuous elution gel electrophoresis for purification of sufficient mpzl3 dimer for solution proteolytic digestion
Equilibrium studies: Assess whether an equilibrium exists between dimer and monomer forms in native conditions, as observed with myelin protein zero in Xenopus
Non-covalent interaction analysis: Investigate potential non-covalent interactions stabilizing mpzl3 dimers through methods like hydrogen-deuterium exchange mass spectrometry
Researchers should be aware that, similar to myelin protein zero, mpzl3 dimers might dissociate into monomers during prolonged elution processes, suggesting the importance of optimizing experimental conditions to maintain native protein states .
Comparative studies between X. laevis and X. tropicalis offer unique opportunities for mpzl3 research:
X. laevis provides advantages for biochemical and cell biological analysis due to larger embryos and higher material yield per embryo (approximately five-fold more than X. tropicalis)
X. tropicalis offers benefits for genetic studies due to its diploid genome and shorter generation time
Comparative analysis can address interesting questions about scaling of organelle, cell, or tissue size between the two species
For mpzl3 research specifically, X. laevis would be the preferred model for proteome analysis and detailed biochemical characterization, while X. tropicalis would be more suitable for genetic screening and inheritance studies . Using both species in complementary ways provides a more comprehensive understanding of mpzl3 function and evolution.
Epigenetic regulation of mpzl3 expression is an area of potential significance, particularly in the context of development. Xenopus serves as an excellent model for epigenetic studies due to its well-characterized developmental stages and the availability of genomic information . Research approaches should consider:
Analysis of DNA methylation patterns in mpzl3 promoter regions across developmental stages
Investigation of histone modifications associated with mpzl3 expression changes
Study of non-coding RNAs that might regulate mpzl3 expression
Examination of chromatin remodeling complexes that influence mpzl3 accessibility
Understanding the epigenetic regulation of mpzl3 could provide insights into its developmental expression patterns and tissue-specific functions, potentially revealing mechanisms that could be targeted for therapeutic interventions in myelin-related disorders.